tiprankstipranks
Tenet Healthcare (THC)
NYSE:THC
US Market
Want to see THC full AI Analyst Report?

Tenet Healthcare (THC) Stock Forecast & Price Target

984 Followers
See the Price Targets and Ratings of:

THC Analyst Ratings

Strong Buy
15Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Tenet
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

THC Stock 12 Month Forecast

Average Price Target

$248.27
▲(26.25% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $248.27 with a high forecast of $280.00 and a low forecast of $210.00. The average price target represents a 26.25% change from the last price of $196.64.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"144":"$144","281":"$281","178.25":"$178.3","212.5":"$212.5","246.75":"$246.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":280,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$280.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":248.26666666666668,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$248.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":210,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$210.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[144,178.25,212.5,246.75,281],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,183.27,190.71076923076924,198.15153846153848,205.5923076923077,213.03307692307692,220.47384615384615,227.9146153846154,235.35538461538462,242.79615384615386,250.23692307692306,257.6776923076923,265.11846153846153,272.5592307692308,{"y":280,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,183.27,188.2697435897436,193.2694871794872,198.26923076923077,203.26897435897436,208.26871794871795,213.26846153846154,218.26820512820512,223.26794871794874,228.2676923076923,233.26743589743592,238.2671794871795,243.2669230769231,{"y":248.26666666666668,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,183.27,185.32615384615386,187.3823076923077,189.43846153846155,191.4946153846154,193.55076923076925,195.60692307692307,197.66307692307691,199.71923076923076,201.7753846153846,203.83153846153846,205.8876923076923,207.94384615384615,{"y":210,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":145.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.12,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.43,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.35,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.49,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":215.13,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.72,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.03,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.12,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.27,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.27,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$280.00Average Price Target$248.27Lowest Price Target$210.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on THC
Bank of America Securities
Bank of America Securities
$230
Buy
16.97%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and AbbVie (NYSE: ABBV)
Robert W. Baird Analyst forecast on THC
Robert W. Baird
Robert W. Baird
$245$210
Hold
6.79%
Upside
Reiterated
05/05/26
Tenet Healthcare price target lowered to $210 from $245 at BairdTenet Healthcare price target lowered to $210 from $245 at Baird
Barclays
$257$238
Buy
21.03%
Upside
Reiterated
05/05/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Stephens Analyst forecast on THC
Unknown Analyst
Stephens
Not Ranked
Stephens
$260
Buy
32.22%
Upside
Reiterated
05/04/26
Stephens Remains a Buy on Tenet Healthcare (THC)
Truist Financial Analyst forecast on THC
Truist Financial
Truist Financial
$270
Buy
37.31%
Upside
Reiterated
05/04/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Kymera Therapeutics (NASDAQ: KYMR)
TD Cowen
$242
Buy
23.07%
Upside
Assigned
05/04/26
Buy Rating Reiterated on Tenet Healthcare as Strong Q1 Execution Supports Upside; $242 Price Target Maintained
Goldman Sachs Analyst forecast on THC
Goldman Sachs
Goldman Sachs
$265$252
Buy
28.15%
Upside
Reiterated
05/03/26
Goldman Sachs Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Morgan Stanley Analyst forecast on THC
Morgan Stanley
Morgan Stanley
$260$254
Buy
29.17%
Upside
Reiterated
05/01/26
Morgan Stanley Sticks to Its Buy Rating for Tenet Healthcare (THC)
KeyBanc
$250$225
Buy
14.42%
Upside
Reiterated
05/01/26
Tenet Healthcare price target lowered to $225 from $250 at KeyBancTenet Healthcare price target lowered to $225 from $250 at KeyBanc
Cantor Fitzgerald Analyst forecast on THC
Cantor Fitzgerald
Cantor Fitzgerald
$245
Buy
24.59%
Upside
Reiterated
04/30/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
RBC Capital Analyst forecast on THC
RBC Capital
RBC Capital
$277$236
Buy
20.02%
Upside
Reiterated
04/30/26
RBC Capital Sticks to Their Buy Rating for Tenet Healthcare (THC)
Guggenheim Analyst forecast on THC
Guggenheim
Guggenheim
$283$252
Buy
28.15%
Upside
Reiterated
04/30/26
Tenet Healthcare price target lowered to $252 from $283 at GuggenheimTenet Healthcare price target lowered to $252 from $283 at Guggenheim
Wells Fargo Analyst forecast on THC
Wells Fargo
Wells Fargo
$265
Buy
34.76%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on THC
Mizuho Securities
Mizuho Securities
$235$265
Buy
34.76%
Upside
Reiterated
03/12/26
Tenet Healthcare price target raised to $265 from $235 at MizuhoTenet Healthcare price target raised to $265 from $235 at Mizuho
J.P. Morgan Analyst forecast on THC
J.P. Morgan
J.P. Morgan
$280
Buy
42.39%
Upside
Reiterated
03/11/26
Analysts' Top Healthcare Picks: BridgeBio Pharma (BBIO), Tenet Healthcare (THC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on THC
Bank of America Securities
Bank of America Securities
$230
Buy
16.97%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and AbbVie (NYSE: ABBV)
Robert W. Baird Analyst forecast on THC
Robert W. Baird
Robert W. Baird
$245$210
Hold
6.79%
Upside
Reiterated
05/05/26
Tenet Healthcare price target lowered to $210 from $245 at BairdTenet Healthcare price target lowered to $210 from $245 at Baird
Barclays
$257$238
Buy
21.03%
Upside
Reiterated
05/05/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Stephens Analyst forecast on THC
Unknown Analyst
Stephens
Not Ranked
Stephens
$260
Buy
32.22%
Upside
Reiterated
05/04/26
Stephens Remains a Buy on Tenet Healthcare (THC)
Truist Financial Analyst forecast on THC
Truist Financial
Truist Financial
$270
Buy
37.31%
Upside
Reiterated
05/04/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Kymera Therapeutics (NASDAQ: KYMR)
TD Cowen
$242
Buy
23.07%
Upside
Assigned
05/04/26
Buy Rating Reiterated on Tenet Healthcare as Strong Q1 Execution Supports Upside; $242 Price Target Maintained
Goldman Sachs Analyst forecast on THC
Goldman Sachs
Goldman Sachs
$265$252
Buy
28.15%
Upside
Reiterated
05/03/26
Goldman Sachs Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Morgan Stanley Analyst forecast on THC
Morgan Stanley
Morgan Stanley
$260$254
Buy
29.17%
Upside
Reiterated
05/01/26
Morgan Stanley Sticks to Its Buy Rating for Tenet Healthcare (THC)
KeyBanc
$250$225
Buy
14.42%
Upside
Reiterated
05/01/26
Tenet Healthcare price target lowered to $225 from $250 at KeyBancTenet Healthcare price target lowered to $225 from $250 at KeyBanc
Cantor Fitzgerald Analyst forecast on THC
Cantor Fitzgerald
Cantor Fitzgerald
$245
Buy
24.59%
Upside
Reiterated
04/30/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
RBC Capital Analyst forecast on THC
RBC Capital
RBC Capital
$277$236
Buy
20.02%
Upside
Reiterated
04/30/26
RBC Capital Sticks to Their Buy Rating for Tenet Healthcare (THC)
Guggenheim Analyst forecast on THC
Guggenheim
Guggenheim
$283$252
Buy
28.15%
Upside
Reiterated
04/30/26
Tenet Healthcare price target lowered to $252 from $283 at GuggenheimTenet Healthcare price target lowered to $252 from $283 at Guggenheim
Wells Fargo Analyst forecast on THC
Wells Fargo
Wells Fargo
$265
Buy
34.76%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on THC
Mizuho Securities
Mizuho Securities
$235$265
Buy
34.76%
Upside
Reiterated
03/12/26
Tenet Healthcare price target raised to $265 from $235 at MizuhoTenet Healthcare price target raised to $265 from $235 at Mizuho
J.P. Morgan Analyst forecast on THC
J.P. Morgan
J.P. Morgan
$280
Buy
42.39%
Upside
Reiterated
03/11/26
Analysts' Top Healthcare Picks: BridgeBio Pharma (BBIO), Tenet Healthcare (THC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

3 Months
xxx
Success Rate
19/25 ratings generated profit
76%
Average Return
+7.84%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.00% of your transactions generating a profit, with an average return of +7.84% per trade.
1 Year
David S MacdonaldTruist Financial
Success Rate
21/27 ratings generated profit
78%
Average Return
+29.72%
Copying David S Macdonald's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +29.72% per trade.
2 Years
xxx
Success Rate
35/39 ratings generated profit
90%
Average Return
+74.14%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 89.74% of your transactions generating a profit, with an average return of +74.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
13
25
25
24
15
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
25
25
24
16
In the current month, THC has received 15 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. THC average Analyst price target in the past 3 months is 248.27.
Each month's total comprises the sum of three months' worth of ratings.

THC Financial Forecast

THC Earnings Forecast

Next quarter’s earnings estimate for THC is $4.20 with a range of $3.58 to $4.47. The previous quarter’s EPS was $4.82. THC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year THC has Performed in-line its overall industry.
Next quarter’s earnings estimate for THC is $4.20 with a range of $3.58 to $4.47. The previous quarter’s EPS was $4.82. THC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year THC has Performed in-line its overall industry.

THC Sales Forecast

Next quarter’s sales forecast for THC is $5.43B with a range of $5.31B to $5.51B. The previous quarter’s sales results were $5.37B. THC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year THC has Performed in-line its overall industry.
Next quarter’s sales forecast for THC is $5.43B with a range of $5.31B to $5.51B. The previous quarter’s sales results were $5.37B. THC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year THC has Performed in-line its overall industry.

THC Stock Forecast FAQ

What is THC’s average 12-month price target, according to analysts?
Based on analyst ratings, Tenet Healthcare’s 12-month average price target is 248.27.
    What is THC’s upside potential, based on the analysts’ average price target?
    Tenet Healthcare has 26.25% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is THC a Buy, Sell or Hold?
          Tenet Healthcare has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Tenet Healthcare’s price target?
            The average price target for Tenet Healthcare is 248.27. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $280.00 ,the lowest forecast is $210.00. The average price target represents 26.25% Increase from the current price of $196.64.
              What do analysts say about Tenet Healthcare?
              Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of THC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.